A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

Clinical trial NCT06679153 · COMPLETED

Trial details

NCT number: NCT06679153
Sponsor: VivaVision Biotech, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anterior Uveitis

Start date: 2023-11-27
Primary completion: 2024-12-29
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.